Financial Compass for Head and Neck Cancer Patients

This study is testing a financial support program called Financial Compass for people with head and neck cancer. We know that financial struggles can make it harder for head and neck cancer patients to do well. This study wants to see if Financial Compass is better than usual care at finding and helping with these financial challenges. You might be able to join if you have head and neck cancer, are experiencing financial hardship (identified by a special survey), and can speak English or Spanish. The main goals are to develop the Financial Compass program and then see if it's practical to use and helpful for patients. About 50 people are expected to participate.

Study design
This is an interventional study that will involve about 50 participants. It includes a pilot randomized controlled trial where participants will either receive the Financial Compass intervention or usual care.
What's involved
Participants in Aim 1 will join advisory boards to discuss and refine the Financial Compass intervention. Participants in Aim 2 will complete a screening questionnaire and, if randomized to the intervention group, receive a needs assessment, tailored care pathway, and weekly support.
Compensation
Not stated in the trial record.
Follow-up
After completing the study intervention, patients are followed up at week 12.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06896695

A Financial Intervention (Financial Compass) to Identify and Address Financial Hardship Among Head and Neck Cancer Patients, Financial Compass Trial

Recruiting
NAAges 18+InterventionalHealth services
Roswell Park Cancer Institute
~50 participants
Updated 2026-06-08 on ClinicalTrials.gov
What's tested:Best PracticeDiscussionFinancial NavigationSurvey Administration

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Development of the Financial Compass intervention (Aim 1)
Measured over Up to 2 years
+1 more outcome measured
Head and Neck Carcinoma
1 sites across 1 states
New York1
  • Elizabeth Bouchard · PRINCIPAL_INVESTIGATOR · Roswell Park Cancer Institute

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

They have been diagnosed with head and neck cancer
Screen positive for financial hardship on the validated Comprehensive Score for Financial Toxicity (COST) measure
Are able to participate in English or Spanish

Exclusion

Adults unable to complete the process of informed consent
Adults whose primary language is not English or Spanish
Individuals who are not yet adults (i.e., infants, children, teenagers)
Unwilling or unable to follow protocol requirements
  • Development of the Financial Compass intervention (Aim 1)Up to 2 years

    Will use stage 1A of the National Institutes of Health Stage Model to further develop the Financial Compass intervention. Will use data from in-depth interviews and collaborative engagement of advisory boards to refine the final Financial Compass intervention package. Will complete the Financial Compass intervention package. Will use the Person, Extended Family, Neighborhood (PEN)-3 model to guide integration of stakeholder feedback into the final Financial Compass intervention package. Will prepare summaries of key findings from the in-depth interviews to review with advisory board members. Themes in advisory board member feedback will be categorized using the main constructs of PEN-3 model in a 3 x 3 table, including (1) perceptions, (2) enablers, and (3) nurturers.

  • Feasibility of the Financial Compass intervention (Aim 2)Up to 12 weeks

    Will assess feasibility of the Financial Compass intervention among head and neck cancer patients. Will examine feasibility through demand (study enrollment rates, reasons for refusal), practicality (retention rates, engagement with intervention sessions/materials, reasons for study drop out), and acceptability (participant satisfaction with intervention materials and content). To assess acceptability, will administer the Acceptability of Intervention Measure (4 items), Intervention Appropriateness Measure (4 items) and Feasibility of Intervention Measure (4 items). The measures use a 5-point Likert scale where 1 = completely disagree and 5 = completely agree and have demonstrated strong psychometric properties. In the Financial Compass group, the measures will be summarized using the appropriate descriptive statistics, with estimates of enrollment and retention rates obtained with 90% confidence intervals.